patent/WO-2005007107-A3

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8268e39ce70ff2ad19742e2a21d5a90c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61938589e83a9b7b1d392a05ae8e69e4
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-426
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4453 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
filingDate	2004-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba898c2c78ff0c96f1ed9b93933bbe9c
publicationDate	2005-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	WO-2005007107-A3
titleOfInvention	Histamine and cck2/gastrin receptor blockade in the treatment of acid-peptic disease and cancer
abstract	The present invention relates to methods useful for treating or preventing gastrointestinal disorders. More specifically, the invention relates to methods for the treatment and prevention of acid reflux disease (GERD), peptic ulcer disease, dyspepsia, gastritis, and pre-malignant and malignant disease of the stomach.
priorityDate	2003-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID774 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID887 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457574898

Total number of triples: 20.